5//SEC Filing
Javitt Jonathan C 5
Accession 0001415889-23-002500
CIK 0001719406other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:14 PM ET
Size
5.6 KB
Accession
0001415889-23-002500
Insider Transaction Report
Form 5
Javitt Jonathan C
DirectorChairman and Chief Scientist10% Owner
Transactions
- Gift
Common Stock, par value $0.001 per share
2022-12-14−300,000→ 14,468,329 total(indirect: By Trust)
Footnotes (3)
- [F1]Donation of 300,000 shares from the Jonathan Javitt Living Trust to the Jonathan Javitt Donor Advised Fund.
- [F2]Charitable Transfer
- [F3]Consists of (i) 12,599,997 shares of common stock held by the Jonathan Javitt Living Trust, (ii) 1,422,000 shares of common stock held by The Javitt 2012 Irrevocable Dynasty Trust, (iii) 146,332 shares of common stock held by Jonathan Javitt individually and (iv) 300,000 held by the Jonathan Javitt Donor Advised Fund. Jonathan Javitt is the trustee of the Jonathan Javitt Living Trust, the Grantor of The Javitt 2012 Irrevocable Dynasty Trust and the donor and primary advisor of the Jonathan Javitt Donor Advised Fund.
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
Related Parties
1- filerCIK 0001303782
Filing Metadata
- Form type
- 5
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:14 PM ET
- Size
- 5.6 KB